By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DelMar Pharmaceuticals 

999 West Broadway
Suite 720
  British Columbia  V5Z 1K5  Canada
Phone: 1-604-629-5989 Fax:



Company News
DelMar Pharmaceuticals Joins OTCQX 12/3/2014 11:38:53 AM
DelMar Pharmaceuticals' Promising New Data Support The Potential Of VAL-083 To Meet Significant Unmet Medical Needs In The Treatment Of Glioblastoma Multiforme 11/17/2014 11:59:21 AM
DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 As A Potential New Treatment In Glioblastoma At The Society Of Neuro-Oncology Annual Meeting 11/14/2014 10:21:23 AM
DelMar Pharmaceuticals Announces September 30, 2014 Results And Provides Corporate Update 11/10/2014 9:32:53 AM
DelMar Pharmaceuticals Invited To Present New Data On VAL-083 In The Treatment Of Glioblastoma Multiforme At The Society For NeuroOncology Annual Meeting 11/6/2014 8:53:22 AM
DelMar Pharmaceuticals Release: VAL-083 Demonstrates Promise As A Potential Treatment For Non-Small Cell Lung Cancer 10/9/2014 9:12:45 AM
DelMar Pharmaceuticals Announces Presentations At Upcoming Scientific Meetings 10/6/2014 11:15:53 AM
DelMar Pharmaceuticals To Present At The SeeThruEquity Fall Microcap Investor Conference 9/8/2014 7:46:46 AM
DelMar Pharmaceuticals Receives Notice Of Allowance For Second U.S. Patent For VAL-083 9/3/2014 11:28:13 AM
DelMar Pharmaceuticals Fiscal 2014 Year End Results And Summary Of Recent Developments 8/29/2014 11:11:59 AM